— Know what they know.
Not Investment Advice
Also trades as: IF0.DE (XETRA) · $vol 0M

IFRX NASDAQ

InflaRx N.V.
1W: +7.8% 1M: -8.8% 3M: +0.6% YTD: +52.3% 1Y: +18.6% 3Y: -17.0% 5Y: -40.1%
$1.66
+0.09 (+5.40%)
 
Weekly Expected Move ±9.5%
$1 $1 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 42 · $244.6M mcap · 126M float · 0.727% daily turnover · Short 38% of daily vol
Credit Risk of going bust: lower than 66% of companies Debt: 0.4% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.00 (down more than 99.9%), InflaRx N.V. would be worth roughly what it owes.
Total debt $927K against a stock market value of $244.6M.
Distance to default 6.92 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $303K (short-term plus half of long-term), stock volatility 91.4%; Altman Z'' 3.85. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$55M -27.4% ▼
5Y CAGR: -9.0%
Total Liabilities
$14M -6.5% ▼
5Y CAGR: +5.7%
Shareholders Equity
$42M -32.4% ▼
5Y CAGR: -11.8%
Cash & Investments
$46M +152.7% ▲
5Y CAGR: -10.6%
Total Debt
$898K +11.5% ▲
5Y CAGR: +9.9%
Net Debt
-$15M +14.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$26M$16M$13M$18M$16M
Short-Term Investments$57M$66M$0$0$30M
Cash & ST Investments$83M$82M$13M$18M$46M
Net Receivables$1M$1M$0$0$1M
Inventory$0$0$11M$7M$0
Other Current Assets$0$3M$85M$46M$6M
Total Current Assets$96M$97M$109M$72M$54M
Property, Plant & Equip.$2M$2M$1M$1M$1M
Goodwill & Intangibles$235K$139K$43K$7K$42K
Long-Term Investments$27M$3M$9M$3M$237K
Other Non-Current Assets$337K$308K$283K$248K$151K
Total Non-Current Assets$29M$5M$11M$4M$2M
Total Assets$125M$102M$120M$76M$55M
— Liabilities —
Accounts Payable$2M$5M$5M$3M$5M
Short-Term Debt$0$0$0$0$257K
Deferred Revenue$8M$6M$0$0$0
Other Current Liabilities$2M-$2M$3M$302K$6M
Total Current Liabilities$19M$13M$17M$14M$13M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$35K$37K$37K$37K$37K
Total Non-Current Liabilities$1M$1M$783K$436K$678K
Total Liabilities$20M$14M$18M$15M$14M
— Equity —
Common Stock$5M$5M$7M$7M$9M
Retained Earnings-$214M-$243M-$286M-$332M-$378M
Accumulated OCI$31M$37M$47M$52M$49M
Total Stockholders Equity$105M$88M$103M$61M$42M
Total Liabilities & Equity$125M$102M$120M$76M$55M
— Key Metrics —
Total Debt$1M$1M$1M$805K$898K
Net Debt-$25M-$15M-$12M-$18M-$15M
Total Investments$84M$68M$9M$3M$31M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms